Literature DB >> 20331929

Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.

Amanda L Baker1, Leanne Hides, Dan I Lubman.   

Abstract

OBJECTIVE: This article systematically reviews the evidence from randomized controlled trials (RCTs) for pharmacologic and psychological approaches to the treatment of cannabis use among individuals with psychotic or depressive disorders. DATA SOURCES: A systematic literature search was conducted using the PubMed and PsychINFO databases from inception to December 2008. Individual searches in cannabis use (search terms: marijuana, cannabis, marijuana abuse, cannabis abuse, marijuana usage, cannabis usage), mental disorders (search terms: mood disorders, affective disorders, anxiety disorders, anxiety, depressive disorder, depression, psychotic disorders, psychosis, mental disorders), and pharmacotherapy (search terms: medication, drug therapy, pharmacotherapy, psychopharmacology, clinical trials, drug trial, treatment trial) were conducted and limited to humans, adolescents and adults. STUDY SELECTION: A search combining the individual cannabis use, mental disorder and pharmacotherapy searches produced 1,713 articles (PubMed = 1,398; PsychINFO = 315). Combining the cannabis use and mental disorder searches while limiting them to English articles and RCTs produced a total of 286 articles (PubMed = 228; PsychINFO = 58). From this literature, there were 7 RCTs conducted among mental health clients that reported cannabis use outcomes using pharmacologic or psychological interventions. DATA SYNTHESIS: While few RCTs have been conducted, there is evidence that pharmacologic and psychological interventions are effective for reducing cannabis use in the short-term among people with psychotic disorders or depression.
CONCLUSIONS: Although it is difficult to make evidence-based treatment recommendations due to the paucity of research in this area, available studies indicate that effectively treating the mental health disorder with standard pharmacotherapy may be associated with a reduction in cannabis use and that longer or more intensive psychological interventions rather than brief interventions may be required, particularly among heavier users of cannabis and those with more chronic mental disorders. Specific recommendations regarding the type and length of specific psychological treatments cannot be made at this time, although motivational interviewing and cognitive-behavioral therapy approaches appear most promising. (c) 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20331929     DOI: 10.4088/JCP.09r05119gry

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 2.  State of the art treatments for cannabis dependence.

Authors:  Itai Danovitch; David A Gorelick
Journal:  Psychiatr Clin North Am       Date:  2012-04-10

Review 3.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

Review 4.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

5.  Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database.

Authors:  Li-Tzy Wu; Ken Gersing; Bruce Burchett; George E Woody; Dan G Blazer
Journal:  J Psychiatr Res       Date:  2011-07-13       Impact factor: 4.791

6.  A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.

Authors:  Taiwo Babatope; Jigar Chotalia; Rania Elkhatib; Satyajit Mohite; Joel Shah; Sumana Goddu; Ruchir Arvind Patel; Osarhiemen Ruth Aimienwanu; Devanshu Patel; Titilayo Makanjuola; Olaoluwa O Okusaga
Journal:  Psychiatr Q       Date:  2016-12

7.  A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Jeng-Jong Pan; Bryce B Reeve; Dan G Blazer
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-20       Impact factor: 4.035

8.  Two Sides of the Same Coin: Cannabis Dependence and Mental Health Problems in Help-Seeking Adolescent and Young Adult Outpatients.

Authors:  Melissa M Norberg; Robert A Battisti; Jan Copeland; Daniel F Hermens; Ian B Hickie
Journal:  Int J Ment Health Addict       Date:  2012-03-28       Impact factor: 3.836

Review 9.  Integrated treatment of substance use and psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley
Journal:  Soc Work Public Health       Date:  2013

10.  Resting-State Directional Connectivity and Anxiety and Depression Symptoms in Adult Cannabis Users.

Authors:  Liangsuo Ma; John M Hettema; Janna Cousijn; James M Bjork; Joel L Steinberg; Lori Keyser-Marcus; Kyle Woisard; QiQi Lu; Roxann Roberson-Nay; Antonio Abbate; F Gerard Moeller
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.